Nanoporous Anodic Alumina-Based Sensor for miR-99a-5p Detection as an Effective Early Breast Cancer Diagnostic Tool.

Fecha de publicación: Fecha Ahead of Print:

Autores de INCLIVA

Participantes ajenos a INCLIVA

  • Pla, Luis
  • Santiago-Felipe, Sara
  • Simon, Soraya
  • Martinez-Manez, Ramon

Grupos y Plataformas de I+D+i

Abstract

Circulating microRNAs have emerged as potential diagnostic biomarkers. The deregulation of the microRNA miR-99a-5p has been previously described as an effective biomarker of early breast cancer. Herein, we present a new nanoporous anodic alumina (NAA)-based biosensor that can detect plasma miR-99a-5p with high sensitivity and selectivity. NAA pores are loaded with rhodamine B and capped with a specific oligonucleotide that is able to block cargo release until the target is present. In the presence of miR-99a-5p, the capping oligonucleotide recognizes the miR-99a-5p sequence and displaces it allowing the release of the encapsulated dye. This method is able to successfully distinguish healthy controls from breast cancer patients, even at early stages with high efficiency, showing the presented system as a promising tool for breast cancer detection.

Datos de la publicación

ISSN/ISSNe:
2379-3694, 2379-3694

ACS Sensors  American Chemical Society

Tipo:
Article
Páginas:
1022-1029
PubMed:
33599490

Citas Recibidas en Web of Science: 14

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • biosensor; breast cancer; diagnosis; nanoporous anodic alumina; plasma

Financiación

Proyectos y Estudios Clínicos

Estudio de los mecanismos de resistencia de células tumorales de cáncer de mama. Implicación de células madre tumorales y transición epitelio mesénquima.

Investigador Principal: IRIS GARRIDO CANO

2015/211 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO

INCORPORACIÓN DE NUEVAS ÁREAS TEMÁTICAS Y NUEVOS GRUPOS AL CONSORCIO CIBER

Investigador Principal: ANA LLUCH HERNÁNDEZ

CB16/12/00481 . INSTITUTO SALUD CARLOS III

Caracterizacion y repercusion terapeutica de la ecologia de cancer de mama HER2 positivo

Investigador Principal: PILAR EROLES ASENSIO

PI18/01219 . INSTITUTO SALUD CARLOS III . 2019

SEOM 2019: DR. JUAN MIGUEL CEJALVO ANDÚJAR

Investigador Principal: JUAN MIGUEL CEJALVO ANDUJAR

00 . FUNDACION SOCIEDAD ESPAÑOLA DE ONCOLOGÍA MEDICA SEOM . 2020

Cita

Compartir